Bullish option flow detected in Viking Therapeutics (VKTX) with 11,408 calls trading, 3x expected, and implied vol increasing almost 4 points to 62.49%. May-26 50 calls and May-26 35 calls are the most active options, with total volume in those strikes near 2,600 contracts. The Put/Call Ratio is 0.11. Earnings are expected on July 29th.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VKTX:
- Nash Maintains Buy on Viking Therapeutics, Keeps $107 Price Target Unchanged Amid Strong Cash Runway and Expanded VK2735 Study
- Viking Therapeutics price target lowered to $100 from $105 at Cantor Fitzgerald
- Viking Therapeutics price target lowered to $95 from $99 at Morgan Stanley
- Viking Therapeutics Maintained at Buy as VK2735 Advances Through Phase 3, Price Target Reaffirmed at $102
- Viking Therapeutics reports Q1 EPS ($1.37), consensus (91c)